
Investors 1
Date | Name | Website |
- | LAV | lavfund.co... |
Mentions in press and media 2
Date | Title | Description |
29.04.2022 | IONOVA Announces Clinical Trial Collaboration with MSD to Evaluate INV-1120 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors | SHENZHEN, China, April 29, 2022 /PRNewswire/ -- Shenzhen IONOVA Life Science Co., Ltd. announces today it has entered into a clinical trial collaboration agreement with MSD (Merck & Co., Inc., Kenilworth, NJ., USA) to evaluate clinical ... |
27.08.2021 | IONOVA Life Science Announces New Financing Round of USD $100 Million | SHENZHEN, China, Aug. 27, 2021 /PRNewswire/ -- On August 27, 2021, Shenzhen IONOVA Life Science Co., Ltd. ("IONOVA" or "the company"), a clinical-stage biotechnology company located in the Guangdong-Hong Kong-Macao Great... |